- Home
- ALBT vs YCBD Comparison
ALBT vs YCBD Comparison
Compare ALBT & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- YCBD
- Stock Information
- Founded
- ALBT 2014
- YCBD 2015
- Country
- ALBT United States
- YCBD United States
- Employees
- ALBT N/A
- YCBD N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- ALBT Health Care
- YCBD Health Care
- Exchange
- ALBT Nasdaq
- YCBD Nasdaq
- Market Cap
- ALBT 3.1M
- YCBD 3.2M
- IPO Year
- ALBT N/A
- YCBD N/A
- Fundamental
- Price
- ALBT $5.42
- YCBD $0.45
- Analyst Decision
- ALBT
- YCBD
- Analyst Count
- ALBT 0
- YCBD 0
- Target Price
- ALBT N/A
- YCBD N/A
- AVG Volume (30 Days)
- ALBT 27.1K
- YCBD 2.0M
- Earning Date
- ALBT 04-14-2025
- YCBD 02-13-2025
- Dividend Yield
- ALBT N/A
- YCBD N/A
- EPS Growth
- ALBT N/A
- YCBD N/A
- EPS
- ALBT N/A
- YCBD N/A
- Revenue
- ALBT N/A
- YCBD $19,220,238.00
- Revenue This Year
- ALBT N/A
- YCBD $13.00
- Revenue Next Year
- ALBT N/A
- YCBD $10.00
- P/E Ratio
- ALBT N/A
- YCBD N/A
- Revenue Growth
- ALBT N/A
- YCBD N/A
- 52 Week Low
- ALBT $2.11
- YCBD $0.31
- 52 Week High
- ALBT $21.60
- YCBD $1.34
- Technical
- Relative Strength Index (RSI)
- ALBT 78.62
- YCBD 42.04
- Support Level
- ALBT $3.33
- YCBD $0.42
- Resistance Level
- ALBT $3.73
- YCBD $0.69
- Average True Range (ATR)
- ALBT 0.35
- YCBD 0.06
- MACD
- ALBT 0.19
- YCBD -0.02
- Stochastic Oscillator
- ALBT 91.63
- YCBD 10.98
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.